BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Cipher Pharmaceuticals Reports Q1 2018 Results

  Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three months ended March 31, 2018.

  May 10, 2018

   · 

  6 min read
• Biotech Beach

  GenomeDx Biosciences’ Genomic Data Featured at 2018 AUA Conference in Multiple Prostate and Bladder Cancer Presentations

  -- Presentations Highlight Versatility of Decipher Tests and Decipher GRID Technology Platform --

  May 10, 2018

   · 

  4 min read
• Teva Canada Announces the Launch of Teva-Cyclosporine Ophthalmic Emulsion, the First Generic Version of Restasis in Canada for the Treatment of Dry Eye Disease

  Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced the launch of Teva-Cyclosporine® ophthalmic emulsion, 0.05% w/v, a Health Canada approved twice-daily eye drop solution and the first generic version of Restasis® (cyclosporine) in Canada.

  May 10, 2018

   · 

  6 min read
• Biotech Bay

  Talis Biomedical Corporation awarded $4.4M by CARB-X

  To fund development of rapid point-of-care diagnostic tests for pathogen identification and antibiotic susceptibility

  May 10, 2018

   · 

  3 min read